Adverse Drug Reaction reports for cardiometabolic drugs from sub-Saharan Africa: a study in VigiBase-Reference-Cited by-同舟云学术

Adverse Drug Reaction reports for cardiometabolic drugs from sub-Saharan Africa: a study in VigiBase

Published:2015-03-18 Issue:6 Volume:20 Page:797-806
ISSN:1360-2276
Container-title:Tropical Medicine & International Health
language:en
Short-container-title:Trop Med Int Health

Author:

Berhe Derbew Fikadu¹²,Juhlin Kristina³,Star Kristina³,Beyene Kidanemariam G. M.⁴,Dheda Mukesh⁵,Haaijer-Ruskamp Flora M.¹,Taxis Katja⁶,Mol Peter G. M.¹⁷

Affiliation:

1. Department of Clinical Pharmacy and Pharmacology; University Medical Centre Groningen; University of Groningen; Groningen The Netherlands

2. Department of Pharmacy; College of Health Sciences; Mekelle University; Mekelle Tigray Ethiopia

3. Uppsala Monitoring Centre; WHO Collaborating Centre for International Drug Monitoring; Uppsala Sweden

4. pharmacovigilince centre; Regulatory Standards Setting and Information Delivery Directorate; Addis Ababa Ethiopia

5. pharmacovigiliance Unit; Medicines Regulatory Authority; National Department of Health; Pretoria South Africa

6. Department of Pharmacy; Unit Pharmacotherapy & Pharmaceutical Care; University of Groningen; Groningen The Netherlands

7. Dutch Medicines Evaluation Board; Utrecht The Netherlands

Funder

Netherlands Organization for International Cooperation in Higher Education

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Parasitology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tmi.12481/fullpdf

Reference35 articles.

1. WHO Global Health Observatory, World Health Statistics 2013a http://www.who.int/gho/publications/world_health_statistics/2013/en/

2. Uppsala Monitoring Cente (UMC) WHO Programme Members.Countries participating in the WHO Programme for International Drug Monitoring, with year of joining 2014 http://www.who-umc.org/DynPage.aspx?id=100653&mn1=7347&mn2=7252&mn3=7322&mn4=7442

3. Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis;Olsson;Drug Saf,2010

4. Pharmacovigilance for antiretroviral drugs in Africa: lessons from a study in Abidjan, Cote d'Ivoire;Jaquet;Pharmacoepidemiol Drug Saf,2011

5. Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring;Kuemmerle;Malar J,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Healthcare Professionals' Knowledge, Attitudes, and Practices Regarding Adverse Drug Reaction Reporting in Ethiopia;Turkish Journal of Pharmaceutical Sciences;2022-10-07

2. Challenges and lessons learned from four years of planning and implementing pharmacovigilance enhancement in sub-Saharan Africa;BMC Public Health;2022-08-17

3. Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi;Drug Safety;2020-04-01

4. Adverse drug reaction reporting practice and associated factors among medical doctors in government hospitals in Addis Ababa, Ethiopia;PLOS ONE;2020-01-21

5. Adverse drug reaction profile in Amravati region of India: A pharmacovigilance study;Journal of Pharmacy And Bioallied Sciences;2020